Literature DB >> 6329503

Transcatheter chemo-embolization effective for treating hepatocellular carcinoma. A histopathologic study.

M Sakurai, J Okamura, C Kuroda.   

Abstract

A histopathologic study was done on livers from 14 patients who underwent surgery for hepatocellular carcinoma and who had been pretreated by a combination of intra-arterial embolization of Gelfoam (Upjohn) plus intra-arterial chemotherapy. This technique was effective as the excess vascularity of the tumor and the tumor bulk were reduced and resection was readily facilitated. For solitary tumors of less than 4 cm in diameter, this approach was particularly effective. As this combined treatment almost invariably leads to liquefaction and necrosis of the tumor, the likelihood of metastases is diminished.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6329503     DOI: 10.1002/1097-0142(19840801)54:3<387::aid-cncr2820540303>3.0.co;2-w

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  46 in total

1.  A prospective randomized controlled trial of preoperative whole-liver chemolipiodolization for hepatocellular carcinoma.

Authors:  Masaki Kaibori; Noboru Tanigawa; Shuji Kariya; Hiroki Ikeda; Yoshitsugu Nakahashi; Junko Hirohara; Chizu Koreeda; Toshihito Seki; Satoshi Sawada; Kazuichi Okazaki; A-Hon Kwon
Journal:  Dig Dis Sci       Date:  2012-01-24       Impact factor: 3.199

2.  Treatment of unresectable hepatocellular carcinoma: results of a randomized controlled trial.

Authors:  E C Lai; T K Choi; S W Tong; G B Ong; J Wong
Journal:  World J Surg       Date:  1986-06       Impact factor: 3.352

3.  A pre-operative chemoembolization therapy using lipiodol, cisplatin and gelatin sponge for hepatocellular carcinoma.

Authors:  S Imaoka; Y Sasaki; T Shibata; M Fujita; H Kasugai; J Kojima; S Ishiguro; H Ohigashi; O Ishikawa; I Fukuda
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  The role of surgery in the management of unusual complications of transcatheter arterial embolization for hepatocellular carcinoma.

Authors:  K S Jeng; H J Ching
Journal:  World J Surg       Date:  1988-06       Impact factor: 3.352

5.  Primary hepatocellular carcinoma--recent advances and future prospects.

Authors: 
Journal:  West J Med       Date:  1985-10

6.  Active inflammatory change of the liver as a cause of postoperative hepatic failure.

Authors:  M Sakurai; J Okamura; C Kuroda; T Yamada
Journal:  Jpn J Surg       Date:  1986-11

7.  [Regression and therapy-resistance of primary liver tumors and liver metastases after regional chemotherapy and local tumor ablation].

Authors:  H-P Fischer
Journal:  Pathologe       Date:  2005-05       Impact factor: 1.011

8.  Extracorporeal hemofiltration: a model for decreasing systemic drug exposure with intra-arterial chemotherapy.

Authors:  R A Graham; Z H Siddik; D C Hohn
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

9.  Lipiodol retention and massive necrosis after lipiodol-chemoembolization of hepatocellular carcinoma: correlation between computed tomography and histopathology.

Authors:  T Imaeda; Y Yamawaki; M Seki; H Goto; G Iinuma; M Kanematsu; R Mochizuki; H Doi; S Saji; K Shimokawa
Journal:  Cardiovasc Intervent Radiol       Date:  1993 Jul-Aug       Impact factor: 2.740

10.  Hepatic arterial infusion chemotherapy for hepatocellular carcinoma with portal vein tumor thrombosis.

Authors:  Yung-Chih Lai; Cheng-Yen Shih; Chin-Ming Jeng; Sien-Sing Yang; Jui-Ting Hu; Yung-Chuan Sung; Han-Ting Liu; Shaw-Min Hou; Chi-Hwa Wu; Tzen-Kwan Chen
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.